Home Page > Hearing - 110th Congress

HEARING

Science and Mission at Risk: FDA’s Self-Assessment

Subcommittee on Oversight and Investigations
Tuesday, January 29, 2008, 10:00 a.m.
2123 Rayburn House Office Building

Hearing Webcast

(Any use of this recording is subject to Rule XI, 4 of the House of Representatives. See text of Rule XI, 4 as posted by the House Committee on Rules.)

Connect to the Archived Video Webcast of this Hearing or Download

Windows Media Player is required to view Committee Web casts.
Note: A version for Mac users is available on Microsoft's Web site.

Witness List & Prepared Testimony

Please click on the name of the witness to link to their prepared testimony. The testimony is available in Adobe pdf file format.

Panel I
Gail H. Cassell, Ph.D. Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases Eli Lilly and Company Lilly Corporate Center, DC 1050 Indianapolis, IN 46285	Mr. Peter Barton Hutt Covington & Burling LLP 1201 Pennsylvania Avenue, NW Washington, DC 20004 Attachment
Catherine E. Woteki, Ph.D. Global Director of Scientific Affairs Mars, Inc. 6885 Elm Street McLean, VA 22101–3883	Dale Nordenberg, M.D. Managing Director Healthcare Industry Advisory PriceWaterhouseCoopers 10 Tenth Street, Suite 1400 Atlanta, GA 30309
Garret A. FitzGerald, M.D. Professor of Medicine and Professor and Chair of Pharmacology Department of Pharmacology University of Pennsylvania School of Medicine 153 Johnson Pavilion 3620 Hamilton Walk Philadelphia, PA 19104–6084
Panel II
Marcia G. Crosse, Ph.D. Director, Health Care U.S. Government Accountability Office 441 G Street, NW, Room 5K21 Washington, DC 20548	Ms. Lisa Shames Director Food and Agriculture Issues U.S. Government Accountability Office 441 G Street N.W., Room 2T23A Washington, DC 20548
Donna V. Porter, Ph.D., R.D. Specialist in Food Safety and Nutrition Domestic Social Policy Division Congressional Research Service Library of Congress 101 Independence Ave., SE Washington, DC 20540–7460
Panel III
The Honorable Andrew C. von Eschenbach, M.D. Commissioner Food and Drug Administration U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857

Additional Documents:
The Science Board Report
Appendices A-K
Appendices L-M
Action Plan for Import Safety
HHS/FDA Food Protection Plan - November 2007

Hearing Transcript

Not available at this time. The printed hearing should be available within 90-120 days of the conclusion of the hearing. When available, the text of the printed hearing may be viewed at the U.S. Government Printing Office Web site.